Inventor · disambiguated record
Marcie Glicksman
Also filed as: GLICKSMAN MARCIE · GLICKSMAN MARCIE A · GLICKSMAN MARCIE ANN
30 granted patents·32 pending applications·369 citations·filing 1993–2025
96Inventor score
Files withORIG3N INC15ENCLEAR THERAPIES INC12CEPHALON INC7SAPPHIROS AI BIO LLC4MASSACHUSETTS EYE & EAR INFIRMARY3
Top patents by PatentIndex Score
62 records- 0193US10653676B2Small molecule inhibitors of USP1 deubiquitinating enzyme activityDANA FARBER CANCER INST INC·Filed 2016·Granted May 19, 2020·9 cites·12 claims
- 0292US11278657B2Methods of amelioration of cerebrospinal fluid and devices and systems thereforENCLEAR THERAPIES INC·Filed 2020·Granted Mar 22, 2022·7 cites·29 claims
- 0391US8188131B2Compounds that enhance Atoh1 expressionEDGE ALBERT·Filed 2009·Granted May 29, 2012·19 cites·34 claims
- 0489US10406163B2Compounds that enhance Atoh1 expressionMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2016·Granted Sep 10, 2019·6 cites·3 claims
- 0589US5461146ASelected protein kinase inhibitors for the treatment of neurological disordersCEPHALON INC·Filed 1993·Granted Oct 24, 1995·71 cites·4 claims
- 0688US9518032B2Small molecule inhibitors of USP1 deubiquitinating enzyme activityD'ANDREA ALAN D·Filed 2011·Granted Dec 13, 2016·14 cites·3 claims
- 0785US5468872AK-252a functional derivatives potentiate neurotrophin-3 for the treatment of neurological disordersCEPHALON INC·Filed 1993·Granted Nov 21, 1995·45 cites·3 claims
- 0884US9447075B2Pyridazine derivatives as EAAT2 activatorsCUNY GREGORY D·Filed 2012·Granted Sep 20, 2016·12 cites·16 claims
- 0983US8859597B2Compounds that enhance Atoh1 expressionEDGE ALBERT·Filed 2012·Granted Oct 14, 2014·5 cites·30 claims
- 1081US5516772AK-252 derivatives which enhance neurotrophin-induced activityCEPHALON INC·Filed 1994·Granted May 14, 1996·38 cites·9 claims
- 1180US2025177109A1Systems and methods of assisted reproduction and prevention of genetic defects in offspring using induced pluripotent stem cellsSapphiros Al Bio LLC·Filed 2024·Application pending·0 cites
- 1278US5621101AProtein kinase inhibitors for treatment of neurological disordersCEPHALON INC·Filed 1995·Granted Apr 15, 1997·48 cites·16 claims
- 1378US5621100AK-252a derivatives for treatment of neurological disordersCEPHALON INC·Filed 1994·Granted Apr 15, 1997·49 cites·1 claims
- 1478US2025111893A1Systems and methods for customizing cell culture media for optimized cell proliferation based on genetic traits of cellsSapphiros Al Bio LLC·Filed 2024·Application pending·0 cites
- 1576US2025295852A1Subarachnoid fluid management method and systemENCLEAR THERAPIES INC·Filed 2025·Application pending·0 cites
- 1676US2025295853A1Subarachnoid fluid management method and system with varying ratesENCLEAR THERAPIES INC·Filed 2025·Application pending·0 cites
- 1775US11160808B2Compounds that enhance Atoh1 expressionMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2019·Granted Nov 2, 2021·0 cites·8 claims
- 1874US8927545B2Inhibiting Eph B-3 kinaseQIAO LIXIN·Filed 2010·Granted Jan 6, 2015·7 cites·15 claims
- 1974US2025312524A1Methods of amelioration of cerebrospinal fluid and devices and systems thereforENCLEAR THERAPIES INC·Filed 2025·Application pending·0 cites
- 2073US9359363B2Identification of compounds that disperse TDP-43 inclusionsWOLOZIN BENJAMIN·Filed 2012·Granted Jun 7, 2016·2 cites·15 claims
- 2173US2024026303A1Systems, methods, and apparatus for induced pluripotent stem cell isolation and combinatorial productionSAPPHIROS AI BIO LLC·Filed 2023·Application pending·0 cites
- 2272US10336768B2Pyrimidine compounds and methods using the sameYUMA THERAPEUTICS INC·Filed 2015·Granted Jul 2, 2019·2 cites·33 claims
- 2370US12337140B2Subarachnoid fluid management method and system with varying ratesENCLEAR THERAPIES INC·Filed 2021·Granted Jun 24, 2025·0 cites·11 claims
- 2470US12329930B2Subarachnoid fluid management method and systemENCLEAR THERAPIES INC·Filed 2021·Granted Jun 17, 2025·0 cites·15 claims
- 2570US9126938B2Phosphatidylcholine transfer protein inhibitorsCOHEN DAVID·Filed 2010·Granted Sep 8, 2015·2 cites·21 claims
- 2669US5756494AProtein kinase inhibitors for treatment of neurological disordersCEPHALON INC·Filed 1995·Granted May 26, 1998·23 cites·43 claims
- 2766US12350416B2Methods of amelioration of cerebrospinal fluid and devices and systems thereforENCLEAR THERAPIES INC·Filed 2022·Granted Jul 8, 2025·0 cites·21 claims
- 2864US9433610B2Compounds that enhance Atoh1 expressionMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2014·Granted Sep 6, 2016·0 cites·25 claims
- 2964US2025270281A1Allogeneic car-t platform using hla-matched bank of ipscs, and related compositions, systems, and methodsSapphiros Al Bio LLC·Filed 2025·Application pending·0 cites
- 3062US12087399B2Systems and methods for customizing cell culture media for optimized cell proliferation based on genetic traits of cellsSAPPHIROS AI BIO LLC·Filed 2018·Granted Sep 10, 2024·0 cites·18 claims
- 3162US2021363154A1Pyrimidine compounds and methods using the sameYUMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3262US2024285854A1Csf therapeutic delivery systemENCLEAR THERAPIES INC·Filed 2024·Application pending·0 cites
- 3361US9212209B2Screening methods for spinal muscular atrophyUNIV INDIANA RES & TECH CORP·Filed 2013·Granted Dec 15, 2015·0 cites·15 claims
- 3460US12115037B2Systems and methods of assisted reproduction and prevention of genetic defects in offspring using induced pluripotent stem cellsSAPPHIROS AI BIO LLC·Filed 2018·Granted Oct 15, 2024·0 cites·16 claims
- 3559US11692174B2Systems, methods, and apparatus for induced pluripotent stem cell isolation and combinatorial productionSAPPHIROS AI BIO LLC·Filed 2018·Granted Jul 4, 2023·0 cites·12 claims
- 3659US10961254B2Pyrimidine compounds and methods using the sameYUMA THERAPEUTICS INC·Filed 2019·Granted Mar 30, 2021·0 cites·18 claims
- 3757US2023321412A1System and method for managing cancer cells in csfENCLEAR THERAPIES INC·Filed 2023·Application pending·0 cites
- 3854US5741808AProtein kinase inhibitors for treatmen of neurological disordersCEPHALON INC·Filed 1997·Granted Apr 21, 1998·10 cites·8 claims
- 3954US2022355015A1Csf diagnostics platformENCLEAR THERAPIES INC·Filed 2022·Application pending·0 cites
- 4054US2022188901A1Systems and methods for determining and presenting purchase recommendations based on personal genetic profilesORIG3N INC·Filed 2022·Application pending·0 cites
- 4153US2022235329A1Methods for generating induced pluripotent stem cells via cell cycle synchronizationORIG3N INC·Filed 2021·Application pending·0 cites
- 4251US2022313890A1Method of regulating gene expressionENCLEAR THERAPIES INC·Filed 2022·Application pending·0 cites
- 4351US2022105322A1System and Method for Controlling CSF Flow and Managing Intracranial PressureENCLEAR THERAPIES INC·Filed 2021·Application pending·0 cites
- 4450US2020027526A1Systems and methods for creation of personal genetic profile productsORIG3N INC·Filed 2017·Application pending·0 cites
- 4549US2020206267A1Allogeneic car-t platform using hla-matched bank of ipscs, and related compositions, systems, and methodsORIG3N INC·Filed 2018·Application pending·0 cites
- 4648US2016052935A1Compounds for use in screening methods for spinal muscular atrophyUNIV INDIANA RES & TECH CORP·Filed 2015·Application pending·0 cites
- 4748US2018218434A1Systems and methods for determining and presenting purchase recommendations based on personal genetic profilesORIG3N INC·Filed 2017·Application pending·0 cites
- 4847US2018173842A1Systems and methods for creation of personal genetic profile productsORIG3N INC·Filed 2017·Application pending·0 cites
- 4947US2018245051A1Methods for generating induced pluripotent stem cells via cell cycle synchronizationORIG3N INC·Filed 2018·Application pending·0 cites
- 5046US2017088515A1Identification of compounds that disperse tdp-43 inclusionsAQUINNAH PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →